marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-30-2024
Intra-Cellular Therapies Cash Flow 2011-2024 | ITCI
Annual Cash Flow Intra-Cellular Therapies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-124 M | -270 M | -260 M | -230 M | -128 M | -118 M | -80.5 M | -91.3 M | - | - | - | - | - |
Depreciation & Amortization |
528 K | 656 K | 533 K | 528 K | 477 K | 369 K | 214 K | 197 K | 140 K | 25.5 K | 23.2 K | 47.7 K | - |
Accounts Payables |
11.5 M | 10.4 M | 8.69 M | 5.5 M | 7.43 M | 14 M | 6.17 M | 3.75 M | 1.63 M | 2.05 M | 3.4 M | - | - |
Accounts Receivables |
114 M | 75.2 M | 20.2 M | 10.8 M | - | - | - | 94.3 K | 30.7 K | 51.6 K | 336 K | - | - |
Total Inventories |
11.6 M | 23.9 M | 7.95 M | 7.06 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Intra-Cellular Therapies
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -34.1 M | - | - | - | -60.1 M | - | -231 M | -178 M | -82.8 M | - | -186 M | -107 M | -47.8 M | - | -162 M | -98.3 M | -51.2 M | - | -92.9 M | -62.9 M | -35.6 M | - | -89 M | -60.6 M | -27 M | - | -55.7 M | -41.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -9.92 K | - | - | -14.8 M | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 132 K | - | - | - | 134 K | - | 513 K | 343 K | 171 K | - | 387 K | 253 K | 127 K | - | 121 K | 132 K | 149 K | - | 129 K | 105 K | 101 K | - | 273 K | 178 K | 82.5 K | - | 155 K | 102 K | 50.4 K | - | 147 K | 96.7 K | 48 K | - | 92.6 K | 47.1 K | 15.2 K | - | 6.41 K | 6.43 K | 6.32 K | - | 4.73 K | 11.1 K | 6.2 K | - | 39.4 K | - | - | - | - | - | - |
Accounts Payables |
10.3 M | 17.5 M | 11.5 M | 11.5 M | 10.6 M | 7.73 M | 8.44 M | 10.4 M | 14.2 M | 10.7 M | 11.6 M | 8.69 M | 12 M | 15.9 M | 8.72 M | 5.5 M | 5.5 M | 5.5 M | 5.5 M | 7.43 M | 7.43 M | 7.43 M | 7.43 M | 14 M | 14 M | 14 M | 14 M | 6.17 M | 6.17 M | 6.17 M | 6.17 M | 3.75 M | 3.75 M | 3.75 M | 3.75 M | 1.63 M | 1.63 M | 1.63 M | 1.63 M | 2.05 M | 2.05 M | 2.05 M | 2.05 M | 3.4 M | 3.4 M | 3.4 M | 3.4 M | 41.6 K | 41.6 K | - | - | - | - | - | - |
Accounts Receivables |
146 M | 146 M | 131 M | 114 M | 103 M | 96 M | 81.5 M | 75.2 M | 61.5 M | 47 M | 32.8 M | 20.2 M | 16.9 M | 15.2 M | 13.7 M | 10.8 M | 10.8 M | 10.8 M | 10.8 M | - | - | - | - | - | - | - | - | - | 6.31 K | 61.9 K | 68.2 K | 94.3 K | 94.3 K | 94.3 K | 94.3 K | 30.7 K | 30.7 K | 30.7 K | 30.7 K | 51.6 K | 51.6 K | 51.6 K | 51.6 K | 336 K | 336 K | 336 K | 336 K | 300 K | 300 K | - | - | - | - | - | - |
Total Inventories |
23.5 M | 20.1 M | 15.9 M | 11.6 M | 43 M | 41.9 M | 28.3 M | 23.9 M | 23.6 M | 25 M | 7.89 M | 7.95 M | 8.17 M | 7.77 M | 7.58 M | 7.06 M | 7.06 M | 7.06 M | 7.06 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency